Los Angeles Capital Management LLC acquired a new stake in Doximity, Inc. (NASDAQ:DOCS – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 10,262 shares of the company’s stock, valued at approximately $287,000.
A number of other institutional investors have also recently made changes to their positions in DOCS. William Blair Investment Management LLC acquired a new stake in shares of Doximity in the first quarter worth approximately $148,823,000. Swedbank AB acquired a new stake in shares of Doximity in the first quarter worth approximately $91,673,000. Norges Bank acquired a new stake in shares of Doximity in the fourth quarter worth approximately $35,995,000. Capital World Investors boosted its stake in shares of Doximity by 250.7% in the first quarter. Capital World Investors now owns 1,714,707 shares of the company’s stock worth $46,143,000 after acquiring an additional 1,225,707 shares during the last quarter. Finally, Janus Henderson Group PLC boosted its stake in shares of Doximity by 33.5% in the first quarter. Janus Henderson Group PLC now owns 2,474,695 shares of the company’s stock worth $66,594,000 after acquiring an additional 621,590 shares during the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.
Insider Activity at Doximity
In related news, CFO Anna Bryson sold 30,000 shares of the business’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $35.00, for a total value of $1,050,000.00. Following the sale, the chief financial officer now owns 309,627 shares in the company, valued at approximately $10,836,945. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, CFO Anna Bryson sold 30,000 shares of the business’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the completion of the transaction, the chief financial officer now directly owns 309,627 shares of the company’s stock, valued at approximately $10,836,945. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Kira Scherer Wampler sold 2,500 shares of the business’s stock in a transaction on Monday, July 1st. The stock was sold at an average price of $28.00, for a total value of $70,000.00. Following the transaction, the director now directly owns 10,258 shares of the company’s stock, valued at $287,224. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 37,951 shares of company stock worth $1,271,018. 39.40% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
View Our Latest Report on DOCS
Doximity Trading Up 2.9 %
DOCS stock opened at $39.32 on Monday. The company has a market capitalization of $7.29 billion, a PE ratio of 54.61, a P/E/G ratio of 5.15 and a beta of 1.27. Doximity, Inc. has a 12-month low of $19.71 and a 12-month high of $39.69. The business’s fifty day moving average price is $32.16 and its 200 day moving average price is $28.67.
Doximity (NASDAQ:DOCS – Get Free Report) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.06. The firm had revenue of $126.68 million for the quarter, compared to the consensus estimate of $119.88 million. Doximity had a return on equity of 19.26% and a net margin of 32.53%. Research analysts predict that Doximity, Inc. will post 0.8 EPS for the current fiscal year.
Doximity Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Read More
- Five stocks we like better than Doximity
- Where Do I Find 52-Week Highs and Lows?
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- How to Read Stock Charts for Beginners
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.